Publications
5808 Results
- Journal / Conference
- British Journal of Haematology 151(2):143-151
- Year
- 2010
- Research Committee(s)
- Lymphoma
- PMID
- PMID20735398
- PMC
- PMC3615251
- Study Number(s)
- E4494
Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI)
- Journal / Conference
- Journal of the National Cancer Institute 102(17):1371
- Year
- 2010
- Research Committee(s)
- Outcomes and Comparative Effectiveness
A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program PMID20682918;PMC2935476
- Journal / Conference
- Blood 116:abst.#1038; American Society of Hematology 2010 Annual Meeting; oral
- Year
- 2010
- Research Committee(s)
- Leukemia
- Study Number(s)
- E1905
Prolonged administration of Azacitidine with or without Entinostat increases rate of hematologic normalization for myelodysplastic syndrome and acute myeloid leukemia with trilineage cysplasia: results of the E1905 trial
- Journal / Conference
- Blood 116:abst. #601; American Society of Hematology 2010 Annual Meeting; oral
- Year
- 2010
- Research Committee(s)
- Leukemia
- Study Number(s)
- E1905
A 10 day schedule of azacitidine induces more complete cytogenetic remissions than the standard schedule: results of the E1905 study
- Journal / Conference
- Blood 116:abst.#321; American Society of Hematology 2010 Annual Meeting; oral
- Year
- 2010
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8819
Genetic polymorphisms in oxidative stress-related genes correlated with outcome following anthracycline-based therapy for aggressive B-cell non-hodgkins lymphomas
- Journal / Conference
- Blood 116:Abstract 1679; American Society of Hematology Annual Meeting; poster
- Year
- 2010
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500
Over-expression of novel IRF8 splice variants is associated with a significant decrease in relapse-free survival in adult AML patients
- Journal / Conference
- American Society of Hematology 2010 Annual Meeting; oral
- Year
- 2010
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0605
A phase II study of lenalidomide for previously untreated deletion (del) 5q acute myeloid leukemia (AML) patients age 60 or older who are not candidates for remission induction chemotherapy (Southwest Oncology Group study S0605)
- Journal / Conference
- Blood 116:Abstract 589; ASH 2010 Annual Meeting; oral
- Year
- 2010
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
R-CHOP versus (vs) CHOP followed by maintenance rituximab (MR) vs observation in older diffuse large B-cell lymphoma (DLBCL) patients (pts): long-term follow-up of Intergroup E4494/C9793
- Journal / Conference
- Blood 116:abst.#415; American Society of Hematology 2010 Annual Meeting; oral
- Year
- 2010
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496